Discovery of 3,3′-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2020/01/01
-
Indian UGC (journal)
-
Refrences57
-
Citations13
-
Sabria Elderwish
-
Anaïs Audebrand
-
Canan G. Nebigil ORCID (unauthenticated)
-
Laurent Désaubry ORCID (unauthenticated)
Cite
Elderwish, Sabria, et al. “Discovery of 3,3′-Pyrrolidinyl-Spirooxindoles As Cardioprotectant Prohibitin Ligands”. European Journal of Medicinal Chemistry, vol. 186, 2020, p. 111859, https://doi.org/10.1016/j.ejmech.2019.111859.
Elderwish, S., Audebrand, A., Nebigil, C. G., & Désaubry, L. (2020). Discovery of 3,3′-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands. European Journal of Medicinal Chemistry, 186, 111859. https://doi.org/10.1016/j.ejmech.2019.111859
Elderwish S, Audebrand A, Nebigil CG, Désaubry L. Discovery of 3,3′-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands. European Journal of Medicinal Chemistry. 2020;186:111859.
Journal Categories
Medicine
Therapeutics
Pharmacology
Science
Chemistry
Science
Chemistry
Analytical chemistry
You May Also Like
- Coumarin: a potential nucleus for anti-inflammatory molecules
- Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
- Hydrazide–hydrazones as potential antimicrobial agents: overview of the literature since 2010
- Cisplatin: The first metal based anticancer drug
- Medicinal attributes of 1,2,3-triazoles: Current developments
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening | Basic Research in Cardiology |
| 45 | 2019 |
| Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring | Molecular Pharmacology |
| 202 | 2019 |
| Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells | European Journal of Medicinal Chemistry |
| 27 | 2018 |
| The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model | Haematologica |
| 11 | 2018 |
Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway | Journal of Experimental & Clinical Cancer Research |
| 13 | 2018 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 12
is the most frequently represented among the references in this article. It primarily includes studies from Basic Research in Cardiology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The category
Science: Chemistry 7
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled SFPH proteins as therapeutic targets for a myriad of diseases and was published in 2020. The most recent citation comes from a 2024 study titled The Effect of 4-(Dimethylamino)phenyl-5-oxopyrrolidines on Breast and Pancreatic Cancer Cell Colony Formation, Migration, and Growth of Tumor Spheroids. This article reached its peak citation in 2022, with 4 citations. It has been cited in 13 different journals, 23% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.